Covidien PLC (COV)

106.71
1.36 1.26
Prev Close 108.07
Open 107.97
Day Low/High 106.71 / 108.16
52 Wk Low/High 65.97 / 108.57
Volume 24.76M
Avg Volume 3.84M
Exchange
Shares Outstanding 454.51M
Market Cap 48.50B
EPS 3.68
Div & Yield 1.44 (1.30%)

Latest News

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

The recent bid by Mylan to acquire Perrigo offers the latest example of pharma companies that have been seeking growth opportunities.

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

After a robust year of mega-deals in 2014, mid-size device makers are expected to seek partners, fueling even further consolidation.

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic's $49.9 billion acquisition of Covidien -- the largest tax inversion deal ever -- will leave shareholders with a big tax bill, while Medtronic may pay little or no taxes.

Covidien Announces Effectiveness Of Medtronic Transaction Scheme Of Arrangement

Covidien Announces Effectiveness Of Medtronic Transaction Scheme Of Arrangement

Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the scheme of arrangement under which Medtronic acquired Covidien under a new holding company incorporated in Ireland to be named...

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback

Stryker must significantly outperform for all of 2015 just to meet expectations. That's a tall order.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the health services industry lower today.

Today Covidien (COV) Hits New Lifetime High

Today Covidien (COV) Hits New Lifetime High

Trade-Ideas LLC identified Covidien (COV) as a new lifetime high candidate

10 Stocks Billionaire John Paulson Loves: DirecTV, AbbVie and More

10 Stocks Billionaire John Paulson Loves: DirecTV, AbbVie and More

Here's a look at 10 stocks that Paulson & Co. bought in the most recently reported quarter.

Covidien Supports Retreat & Refresh Stroke Camp For Stroke Survivors And Caregivers

Covidien Supports Retreat & Refresh Stroke Camp For Stroke Survivors And Caregivers

Covidien is sponsoring the Retreat & Refresh Stroke Camp (Stroke Camp), a three-day retreat for stroke survivors, caregivers and family members dedicated to helping these often forgotten victims of stroke relax...

Covidien (COV) Stock Rises Today on Earnings Beat

Covidien (COV) Stock Rises Today on Earnings Beat

Covidien (COV) shares are climbing after the company reported its first quarter earnings results.

Covidien Reports First-Quarter 2015 Results

Covidien Reports First-Quarter 2015 Results

Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2015.

What to Expect When Covidien (COV) Reports First-Quarter Earnings Tomorrow

What to Expect When Covidien (COV) Reports First-Quarter Earnings Tomorrow

Shares of Covidien (COV) closed higher Wednesday ahead of the healthcare company's first-quarter earnings report before the market open Thursday.

Announcement Under Irish Takeover Rules Relevant Securities In Issue - January 21, 2015

Announcement Under Irish Takeover Rules Relevant Securities In Issue - January 21, 2015

In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the " Company") confirms that, as of the close of business on January 20, 2015, the Company's issued share capital, excluding treasury...

Ebola Vaccine Sends Johnson & Johnson Stock Higher Ahead of Earnings

Ebola Vaccine Sends Johnson & Johnson Stock Higher Ahead of Earnings

Johnson & Johnson's handsome dividend yield and projected 5.5% annual growth rate for the next five years makes it a solid investment.

Covidien Plc To Report First-Quarter Fiscal 2015 Results On January 22, 2015

Covidien Plc To Report First-Quarter Fiscal 2015 Results On January 22, 2015

Covidien plc (NYSE: COV) will report first-quarter fiscal 2015 results on January 22.

Announcement Under Irish Takeover Rules Relevant Securities In Issue - January 14, 2015

Announcement Under Irish Takeover Rules Relevant Securities In Issue - January 14, 2015

In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the " Company") confirms that, as of the close of business on January 13, 2015, the Company's issued share capital, excluding treasury...

Covidien's Stellarex™ Drug-Coated Angioplasty Balloon Receives CE Mark To Treat Peripheral Arterial Disease Patients

Covidien's Stellarex™ Drug-Coated Angioplasty Balloon Receives CE Mark To Treat Peripheral Arterial Disease Patients

Covidien plc (NYSE:COV) today announced it has received CE Mark approval for its Stellarex™ drug-coated angioplasty balloon (DCB).

Trade-Ideas: Covidien (COV) Is Today's New Lifetime High Stock

Trade-Ideas: Covidien (COV) Is Today's New Lifetime High Stock

Trade-Ideas LLC identified Covidien (COV) as a new lifetime high candidate

Announcement Under Irish Takeover Rules Relevant Securities In Issue - January 8, 2015

Announcement Under Irish Takeover Rules Relevant Securities In Issue - January 8, 2015

In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the " Company") confirms that, as of the close of business on January 7, 2015, the Company's issued share capital, excluding treasury...

Announcement Under Irish Takeover Rules -- Results Of Covidien Plc's Shareholder Meetings

Announcement Under Irish Takeover Rules -- Results Of Covidien Plc's Shareholder Meetings

On January 6, 2015, Covidien plc, a public limited company organized under the laws of Ireland, held a special court-ordered meeting of shareholders and an extraordinary general meeting of shareholders, in each case...

Announcement Under Irish Takeover Rules Relevant Securities In Issue - December 30, 2014

Announcement Under Irish Takeover Rules Relevant Securities In Issue - December 30, 2014

In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the " Company") confirms that, as of the close of business on December 29, 2014, the Company's issued share capital, excluding treasury...

Announcement Under Irish Takeover Rules Relevant Securities In Issue - December 23, 2014

Announcement Under Irish Takeover Rules Relevant Securities In Issue - December 23, 2014

In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the " Company") confirms that, as of the close of business on December 22, 2014, the Company's issued share capital, excluding treasury...

5 Health Care Stocks John Paulson Is Buying Ahead of 2015

5 Health Care Stocks John Paulson Is Buying Ahead of 2015

Here's a closer look at five stocks Paulson & Co. bought in the most recently reported quarter.

Covidien Declares Quarterly Cash Dividend

Covidien Declares Quarterly Cash Dividend

Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.

Covidien's Solitaire Device Was Used In The MR CLEAN Trial. Solitaire Restores Blood Flow And Retrieves Clots From Blocked Blood Vessels In Patients Experiencing Acute Ischemic Stroke.(Photo: Business Wire)

Covidien's Solitaire Device Was Used In The MR CLEAN Trial. Solitaire Restores Blood Flow And Retrieves Clots From Blocked Blood Vessels In Patients Experiencing Acute Ischemic Stroke.(Photo: Business Wire)

In a landmark study evaluating the addition of stent thrombectomy clot removal to pharmaceutical treatment for patients suffering an acute ischemic stroke (AIS), stent thrombectomy provided a significant clinical benefit...

Announcement Under Irish Takeover Rules Relevant Securities In Issue - December 11, 2014

Announcement Under Irish Takeover Rules Relevant Securities In Issue - December 11, 2014

In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the " Company") confirms that, as of the close of business on December 10, 2014, the Company's issued share capital, excluding...